Why choose Thermo Fisher Scientific as your partner in pernicious anemia testing?
Complete, fully automated, portfolio
With an exceptionally high clinical specificity of 99.4% and 89.9%, respectively, combined with a clinical sensitivity of 51.9% and 81.0%, respectively, EliA™ Intrinsic Factor test and EliA™ Parietal Cell test form the best-in-class, fully automated portfolio to aid in the diagnosis of PA.3
Results you can rely on to detect pernicious anemia, sooner
Combining the outstanding sensitivity and specificity of the EliA Intrinsic Factor and EliA Parietal Cell test increases the clinical sensitivity to 91.1% while maintaining specificity at 87%, helping you put the patient first by detecting more patients suffering from PA, sooner.3
Optimized for lean working
EliA Intrinsic Factor test and EliA Parietal Cell test can be measured from one sample in one run and on the same fully automated Phadia™ Laboratory Systems.